Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

A Olagunju, A Owen, TR Cressey - Pharmacogenomics, 2012 - Future Medicine
Mother-to-child-transmission rates of HIV in the absence of any intervention range between
20 and 45%. However, the provision of antiretroviral drugs (ARVs) during pregnancy …

Standby emergency treatment of malaria in travelers: experience to date and new developments

P Schlagenhauf, E Petersen - Expert review of anti-infective …, 2012 - Taylor & Francis
The concept of 'standby emergency treatment'(SBET) describes the strategy where travelers
carry an emergency malaria treatment for self-administration when no medical attention is …

Optimizing therapeutic drug monitoring in pregnant women: a critical literature review

F de Lima Moreira, JR de Lima Benzi… - Therapeutic Drug …, 2023 - journals.lww.com
Background: More than 90% of pregnant women take at least one drug during pregnancy.
Drug dose adjustments during pregnancy are sometimes necessary due to various …

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of …

C Naing, JW Mak, K Aung… - Transactions of the Royal …, 2013 - academic.oup.com
The present review aimed to synthesise available evidence on the efficacy of
dihydroartemisinin-piperaquine (DP) in treating uncomplicated Plasmodium falciparum …

Efficacy and Safety of Dihydroartemisinin-Piperaquine for Treatment of Plasmodium vivax Malaria in Endemic Countries: Meta-Analysis of Randomized Controlled …

C Naing, V Racloz, MA Whittaker, K Aung, SA Reid… - PLoS …, 2013 - journals.plos.org
Background This study aimed to synthesize available evidence on the efficacy of
dihydroartemisinin-piperaquine (DHP) in treating uncomplicated Plasmodium vivax malaria …

The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review

RJ Burger, BJ Visser, MP Grobusch, M van Vugt - Malaria journal, 2016 - Springer
Background Pregnancy has been reported to alter the pharmacokinetic properties of anti-
malarial drugs, including the different components of artemisinin-based combination therapy …

Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia

J Lohy Das, AM Dondorp, F Nosten, AP Phyo… - The AAPS Journal, 2017 - Springer
Orally administered artemisinin-based combination therapy is the first-line treatment against
uncomplicated P. falciparum malaria worldwide. However, the increasing prevalence of …

Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges

K Patel, JA Simpson, KT Batty… - British journal of …, 2015 - Wiley Online Library
Malaria remains a global public health concern and current treatment options are
suboptimal in some clinical settings. For effective chemotherapy, antimalarial drug …

Updated pharmacokinetic considerations for the use of antimalarial drugs in pregnant women

BR Moore, TM Davis - Expert Opinion on Drug Metabolism & …, 2020 - Taylor & Francis
Introduction The association between pregnancy and altered drug pharmacokinetic (PK)
properties is acknowledged, as is its impact on drug plasma concentrations and thus …

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria

KM Jamsen, SB Duffull, J Tarning, N Lindegardh… - Malaria journal, 2011 - Springer
Background Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are
designed primarily by the logistical and ethical constraints of taking blood samples from …